Beamtherapeutics
Manufacturing Science & Technology (MS&T) Co-op
Durham, NC. Posted a month ago
The role
The co-op will support late-stage clinical cell therapy manufacturing operations. Work focuses on projects involving aseptic process simulation, process validation, and regulatory inspection readiness.
What you will do
- Develop a project plan, define objectives, and execute against timelines.
- Support the lifecycle management of the Aseptic Process Simulation (APS) program.
- Support Pre-License Inspection (PLI) readiness activities.
- Prepare technical summaries and presentations for MSAT leadership.
- Maintain compliant documentation practices in accordance with GMP requirements.
Required qualifications
- Currently pursuing a Bachelor's or Master's degree in Chemical Engineering, Bioengineering, Biomedical Engineering, Biotechnology, or a related scientific discipline.
- Must be entering their third or fourth year of undergraduate study or currently pursuing a Master's degree.
- Strong interest in biopharmaceutical manufacturing, cell therapy, sterile manufacturing, or GMP operations.
- Excellent written, verbal, and interpersonal communication skills.
- Strong organizational skills and attention to detail.
- Ability to work effectively within a fast-paced, cross-functional environment.
- Proficiency with Microsoft Office applications including Excel, Word, and PowerPoint.
- Ability to work onsite in Durham, NC
- Ability to occasionally enter manufacturing and laboratory environments while following applicable gowning and safety requirements.
- Ability to sit, stand, and use a computer for extended periods.
Before you apply
- Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the internship/co-op to be eligible.
About the company
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. The company uses base editing technology to advance a diversified portfolio of base editing programs.